The i on MSN10d
‘Game-changing’ chronic and recurrent UTI drug to be rolled out across NHS in weeksGame-changer' drug Hiprex is set to be approved for NHS use - but there is still no official guidance for treating chronic ...
AbbVie (ABBV) shares dip for 7th day, but analysts see buying opportunity after recent setback in schizophrenia drug trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback